PHARMACY

FDA commissioner Scott Gottlieb responded to queries about the government shutdown's effect on drug approvals on Twitter.

FDA's approval of a new Cabometyx indication provides a treatment for patients with liver cancer.

Nexus Pharmaceuticals' generic Busulfex is the company's second oncology generic drug.

Albertsons has chosen Pharmacy Quality Solutions' EQuIPP Analytics for enhanced reporting capabilities.

Vitruvius Therapeutics has received the FDA's blessing for its vitamin B-12 injection, which had a market value of roughly $74.3 million for the year ended September 2018.

In addition to optioning its pharmacy business during the Chapter 11 process, Shopko said it would be closing 38 stores and relocating 20 optical centers to freestanding locations.

Teva has received the Food and Drug Administration's approval for the first generic of Lundbeck's Sabril.

Ferring has acquired U.S. commercialization rights for generic ganirelix acetate injection from Sun Pharma.